Ian Rhodes
2023
In 2023, Ian Rhodes earned a total compensation of $162K as Interim Chief Financial Officer at Akers Biosciences, which was the same as previous year.
Compensation breakdown
| Salary | $162,000 |
|---|---|
| Total | $162,000 |
Rhodes received $162K in salary, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Ian Rhodes' compensation ranked 2,648th out of 2,785 executives tracked by ExecPay. In other words, Rhodes earned more than 4.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,648 out of 2,785 | 5th |
Division Manufacturing | 1,462 out of 1,525 | 4th |
Major group Chemicals And Allied Products | 831 out of 864 | 4th |
Industry group Drugs | 801 out of 827 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 14 out of 14 | 0th |
Source: SEC filing on November 1, 2024.
Rhodes' colleagues
We found three more compensation records of executives who worked with Ian Rhodes at Akers Biosciences in 2023.